Michael Jesselson
YOU?
Author Swipe
View article: CSF inflammatory response after intraventricular hemorrhage
CSF inflammatory response after intraventricular hemorrhage Open
NCT00784134.
View article: Erratum
Erratum Open
View article: Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial
Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial Open
BACKGROUND Minimally invasive thrombolytic evacuation of intracerebral hematoma is being investigated in the ongoing phase III clinical trial of Minimally Invasive Surgery plus recombinant Tissue plasminogen activator for Intracerebral hem…
View article: Demographic Risk Factors for Vascular Lesions as Etiology of Intraventricular Hemorrhage in Prospectively Screened Cases
Demographic Risk Factors for Vascular Lesions as Etiology of Intraventricular Hemorrhage in Prospectively Screened Cases Open
Background: Spontaneous intraventricular hemorrhage (IVH) is associated with high rates of morbidity and mortality despite critical care and other advances. An important step in clinical management is to confirm/rule out an u…
View article: Contents Vol. 43, 2017
Contents Vol. 43, 2017 Open
View article: Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations
Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations Open
OBJECTIVE Vascular permeability and iron leakage are central features of cerebral cavernous malformation (CCM) pathogenesis. The authors aimed to correlate prospective clinical behavior of CCM lesions with longitudinal changes in biomarker…
View article: Peripheral Plasma Vitamin D and Non-HDL Cholesterol Reflect the Severity of Cerebral Cavernous Malformation Disease
Peripheral Plasma Vitamin D and Non-HDL Cholesterol Reflect the Severity of Cerebral Cavernous Malformation Disease Open
Validation of these biomarkers and their potential treatment modulation may influence the clinical care of patients with CCM disease.